BioCentury
ARTICLE | Company News

Therion and Aventis expand cancer alliance

October 26, 2000 7:00 AM UTC

Therion Biologics ( Cambridge, Mass.) and AVE's Aventis Pasteur (Lyon, France) business expanded their 1998 collaboration to study additional tumor-associated antigens for use in pox virus-based vacci...